Next Article in Journal
The Emergence of Multidrug-Resistant Gram-Positive Bloodstream Infections in India—A Single Center Prospective Cohort Study
Previous Article in Journal
Bacteremia and Antimicrobial Resistance Pattern of Uropathogens Causing Febrile Urinary Tract Infection in a Pediatric University Hospital
 
 
GERMS is published by MDPI from Volume 25 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum S.R.L..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting

by
Nitin Bansal
1,*,
Neelam Sachdeva
2,*,
Dinesh Bhurani
3,
Narendra Agarwal
3,
Rayaz Ahmed
3,
Pallavi Mehta
3 and
Rohan Halder
3
1
Infectious Diseases, Rajiv Gandhi Cancer Institute, Sir Chotu Ram Marg, Rohini, Sector 5, New Delhi 110085, India
2
Microbiology, Rajiv Gandhi Cancer Institute, Sir Chotu Ram Marg, Rohini, Sector 5, New Delhi 110085, India
3
Hematology, Rajiv Gandhi Cancer Institute, Sir Chotu Ram Marg, Rohini, Sector 5, New Delhi 110085, India
*
Authors to whom correspondence should be addressed.
GERMS 2023, 13(3), 221-228; https://doi.org/10.18683/germs.2023.1388
Submission received: 7 December 2022 / Revised: 25 May 2023 / Accepted: 10 July 2023 / Published: 30 September 2023

Abstract

Introduction: Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with poor outcomes, particularly among hematology-oncology patients. Appropriate use (selection and de-escalation) of antibiotics is a key component of management of febrile neutropenia particularly in high CRE prevalence regions like India. Methods: This was a retrospective study done (April 2019–December 2021) in a dedicated oncology center in North India, which assessed the case records of the patients undergoing therapy for hematological malignancies who were diagnosed with CRE bacteremia. Demographic, clinical and microbiological data, as well as antibiotic prescription patterns were studied. Inter-group analysis was done between an antibiotic stewardship cohort (avoiding CRE therapy empirically or stopping CRE therapy if cultures negative; as per suggestions of the AMS team) and a non-antibiotic stewardship cohort (continuation of empirical CRE therapy; de-escalation advice was not followed). Results: A total of 139 patients were identified, with median age of 41 years (range 13–74) out of which 82 (58.9%) were males. Acute myeloid leukemia (66.2%) was the most common malignancy, followed by lymphoma (8.6%) and myeloma (8.6%). Nearly 30% of patients were post allogenic stem cell transplant. Klebsiella pneumoniae was the predominant organism (78.4%) and combination of NDM+OXA-48 (46.3%) was the most common carbapenemase gene detected followed by OXA-48 alone (34.7%). Overall, 28-day mortality was 26.6%. On binary logistic regression analysis, lack of compliance with antibiotic stewardship intervention was an independent predictor of mortality (p = 0.005). Conclusions: Prior exposure to empirical CRE therapy or failure to de-escalate was associated with poor outcomes in patients with CRE bacteremia, which gives us a window of antibiotic stewardship in febrile neutropenia.
Keywords: febrile neutropenia; CRE; antibiotic stewardship; hematological malignancies; antibiotic resistance febrile neutropenia; CRE; antibiotic stewardship; hematological malignancies; antibiotic resistance

Share and Cite

MDPI and ACS Style

Bansal, N.; Sachdeva, N.; Bhurani, D.; Agarwal, N.; Ahmed, R.; Mehta, P.; Halder, R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS 2023, 13, 221-228. https://doi.org/10.18683/germs.2023.1388

AMA Style

Bansal N, Sachdeva N, Bhurani D, Agarwal N, Ahmed R, Mehta P, Halder R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS. 2023; 13(3):221-228. https://doi.org/10.18683/germs.2023.1388

Chicago/Turabian Style

Bansal, Nitin, Neelam Sachdeva, Dinesh Bhurani, Narendra Agarwal, Rayaz Ahmed, Pallavi Mehta, and Rohan Halder. 2023. "Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting" GERMS 13, no. 3: 221-228. https://doi.org/10.18683/germs.2023.1388

APA Style

Bansal, N., Sachdeva, N., Bhurani, D., Agarwal, N., Ahmed, R., Mehta, P., & Halder, R. (2023). Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS, 13(3), 221-228. https://doi.org/10.18683/germs.2023.1388

Article Metrics

Back to TopTop